IndiGo ready to resume India-China flights if governments agree; Air India says no immediate plans
Meanwhile, Air India said it had no immediate plans to fly to the neighbouring country.
Indigo released a statement attributed to Elbers which said, 'IndiGo operated daily flights between India and China prior to the Covid-19 pandemic. The airline stands ready to resume these services as soon as the bilateral arrangements between the two countries allow. Guided by its entrepreneurial spirit, IndiGo remains committed to identifying and pursuing commercially viable opportunities.'
On the sidelines of an event organised in the City on Wednesday, Elbers had told mediapersons that if the bilateral arrangements between the two countries would enable operation of the flights, then Indigo would go ahead with it.
'Indigo was operating there prior to COVID and is known for its entrepreneurial spirit. If the governments were to come to an arrangement, then air travel would resume. Clearly Indigo would be ready for it.'
Indigo would begin flying to Athens from India early next year, he added. It would also fly to Copenhagen and London Heathrow in the winter, he added.
Contradicting reports that the Aviation Ministry had asked Air India to be ready along with IndiGo to operate flights next month to China, an Air India source told, 'The Government has not conveyed anything to us in connection with flight operations to China. As of now, we are not having any immediate plans to fly to China in the near future.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
an hour ago
- News18
Why Do Flights To Same Destination Have Different Fares? Codeshare Airlines Explained
Last Updated: What are codeshare flights? Reddit user asks after coming across airline carriers flying the same route listed for different prices despite being operated by Air India. A traveller looking to book a flight came across a unique listing of two different airlines from the same airports of New Delhi to Hong Kong with the same travel time and direct connectivity. Both were operated by Air India with an exact journey duration of 5 hours and 35 minutes, too. The cheaper option, Air India, displayed a price of Rs 9359. While the other subsequent listing of Ethiopian Airlines cost Rs 12624 for the same route. So are the mysterious sky gods at play, or is the customer getting ripped off by being offered the same product in different packaging? This is where the codeshare flight comes into play. Before we proceed, please note that this excludes airline companies that are not part of partnerships or do not belong to the same group. The Listing 'These both are essentially the same flight but is shown as different flight with different flight number and fare (sic)," a Reddit user wrote as they shared a screenshot of Air India and Ethiopian Airlines bound for the same route but priced differently. (Photo shared by Honey_dp) Both flights listed above are operated by the Air India company. 'It's Normal" Responding to the OP's query, fellow travellers informed that it wasn't out of the ordinary and was pretty standard in the commercial aviation industry. One informed about the codeshare between two airline companies. 'It is common when booking via two different airlines who code share. The terms of the booking might also be different. For example, I generally book Lufthansa to fly between US & India. Once I book via United, even though it is Lufthansa that was the actual plane flying, the price was cheaper and the baggage allowance was less, (sic)" wrote one user in response. While another pointed out the Star Alliance group, under which both Air India and Ethiopian Airlines were member airlines. 'As you can see, one is via a Star Alliance partner Ethiopian Airlines. Partners can list flights at prices they seem fit, no obligation to offer the same price (sic)." Although two airline companies' codesharing doesn't necessarily have to be a part of the same alliance or group. For instance, Thai Airways and EVA Air have a codeshare agreement despite not falling under one group or umbrella. Codeshare Agreement To simplify the concept, we will peek at what IndiGo Airlines has to say about the codeshare flight. 'A codeshare flight is one in which one carrier markets and the other operates. They are a result of an agreement between two carriers to sell seats on each other's flights with the aim to offer its customers a large variety of destinations to choose. The flight ticket would be booked on the flight number of the carrier that you have selected to travel with, however, it may be operated by another airline." A common example of this could be booking a seat on Qatar Airways for the New Delhi to Doha route. If your booking indicates that the Qatar Airways flight is operated by IndiGo, you will board an IndiGo flight to Doha. Qatar Airways' job here was to help you book a seat on a flight operated by IndiGo. This works vice versa, too, as the two airline companies code-share. In this instance, Qatar Airways was the marketing carrier that sold you the code-share ticket, and IndiGo became the operating carrier. In the example below for a round-trip from New Delhi to Berlin, one of the listings has only flights operated by Qatar Airways. In the second listing, IndiGo operates one leg of the journey, while Qatar Airways operates all remaining flights. (Qatar Airways) How To Identify A Codeshare Flight? During the flight selection, the customer will be prompted with a remark, an * or simply an airline logo to help identify the codeshare flights. Why Is It Beneficial? Codeshare agreements are beneficial for passengers who are suddenly exposed to a sea of flight options that make their travel plans more flexible. The agreement also enables major carriers to connect to the less-frequented or remote airports, thereby enhancing their global connectivity. In this example of a round-trip journey from New Delhi to Berlin and back, a passenger can save a significant amount on the first listing, which includes one leg of the journey operated by IndiGo. This, despite the duration of the journeys being almost identical in both listings. (Qatar Airways) The codeshare agreement also extends convenience to passengers who do not have to recheck their baggage during the layovers. Interline Agreement Although not as comprehensive as a codeshare agreement, an interline agreement facilitates luggage handling for passengers by airlines on a given itinerary, coordinating among each other. 'An interline agreement involves airlines cooperating to handle passengers traveling on itineraries involving multiple airlines. This agreement includes provisions for baggage handling, allowing for the transfer of luggage, including trolley bags with TSA lock, between different airlines without passengers needing to collect and recheck their bags manually," an excerpt on read. top videos View all There are, however, transits and layovers where passengers are required to recheck their baggage for the onward journey. It's always encouraged to contact the airline(s) ahead of your journey when your itinerary has multiple flights and the layover(s) are of short duration. In some cases, a passenger may also require a transit visa if they are mandated to recheck their baggage for their connecting flight. About the Author Anurag Verma Anurag Verma, News Editor at works independently for the Viral section. Bollywood, Cricket, Science, Tech, YouTube, Reddit, Meme Origins and everything Pop-culture are his forte. He covers More Click here to add News18 as your preferred news source on Google. Get Latest Updates on Movies, Breaking News On India, World, Live Cricket Scores, And Stock Market Updates. Also Download the News18 App to stay updated! tags : Air India Flight Booking view comments Location : New Delhi, India, India First Published: August 15, 2025, 17:16 IST News explainers Why Do Flights To Same Destination Have Different Fares? Codeshare Airlines Explained Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Mint
an hour ago
- Mint
From cramped Delhi room to 155+ outlets across India, how Blue Tokai overcame FSSAI fake licence scare to brew success
Blue Tokai Coffee Roasters started brewing when founder Matt Chittaranjan moved to Chennai from the US in 2011 for a job opportunity. Around that time, the third wave of coffee was rising globally, focusing on the farm-to-cup concept, transparency and traceability. Inspired by this shift, Chittaranjan wanted to bring a similar 'coffee movement' to India. He noticed that speciality coffee—with all its nuance, freshness, and respect for origin—was nowhere to be found in India. The domestic coffee market was mostly dominated by mass-produced blends and street-side kiosks, where coffee was more of a background beverage than a well-crafted experience. This realization, coupled with his partner Namrata Asthana's support, led them to move to Delhi in 2012 to create what would become Blue Tokai, food aggregator platform Zomato wrote in a blog. Chittaranjan and Asthana began their venture with a straightforward mission: to source high-quality Arabica beans directly from Indian producers, roast them fresh, and introduce people to what coffee could truly be. They started small, using a 500-gram coffee roaster, operating right out of Asthana's family home. By 2013, they launched Blue Tokai's first outlet. Despite the gradual success, they hit their first major roadblock when a consultant gave them a fake Food Safety and Standards Authority of India (FSSAI) licence in Mumbai. Police shut them down and that's when they realised that the brand has some operational gaps. During that troubled time, Shivam Shahi joined in on the journey as the third partner and took on the role of Chief Operating Officer. Chittaranjan believes that'this business wouldn't be where it is without him', as reported by Startup Pedia. In the early days, Blue Tokai knew it was ahead of the curve. 'We didn't hire aggressively until 2023 and worked with a small team in those initial years,' Shahi told Zomato. But things changed significantly after the COVID-19 pandemic. 'That's when the business really took off. We grew 4x after that.' Today, according to the Blue Tokai team, the company's food items, including bestselling items like almond croissant, butter croissant, and mushroom sourdough sandwich, play a big role in its overall growth, in addition to its speciality items like Vietnamese-style iced coffee, cappuccino, and trioccino. Currently, Blue Tokai runs 155+ outlets across eight Indian states and Japan. 'About 95% of our business comes from four big cities: Delhi, Mumbai, Pune, and Bangalore,' Shahi said. The decision to expand internationally was inspired by a steady stream of Japanese visitors at its Sikanderpur outlet. 'We realised they were very particular about taste and valued everything we stood for—quality, origin, stories,' says Shahi. This discovery led to its first overseas café in Japan. While growing, the company made sure to customise its offerings by location. 'In Japan, people prefer darker roasts so we adjust our roasting accordingly.' Additionally, it established an FMCG distribution network in Dubai, driven by growing international interest in Indian coffee. As Blue Tokaiplans to enter new cities, including Hyderabad and Dehradun, the brand continues to dive deeper into the brewing journey. Once started with a 500gm roaster and a few passionate individuals, Blue Tokai has now become a brand which weaves a story with each cup, the blog noted.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
PM Modi urges scientists to focus on R&D, secure patents for new drugs
Prime Minister Narendra Modi on Friday urged scientists and entrepreneurs to focus more on research and development (R&D) and secure patents for new drugs and medical technologies to ensure self-reliance in the pharmaceutical segment. Speaking from the Red Fort on the occasion of India's 79th Independence Day, Modi said this would enable the country not only to meet its own healthcare needs but also to emerge as a global hub of medical innovation. The call comes at a time when India has been lagging in R&D spending, according to a Department of Pharmaceuticals (DoP) study paper on industry–academia linkage in the segment. The paper states that while a number of initiatives for industry–academic linkages in India have produced positive research results over the years, their sporadic nature has kept India's share of world researchers at about 2 per cent, compared to 20 per cent in the United States and China. 'An analysis of the share in R&D reveals that in India, the government contributes between 75 and 80 per cent, the private sector 20 to 25 per cent, and universities 3 per cent,' the paper noted. In comparison, OECD countries see 69 per cent of R&D funding from private sector companies, followed by universities at 18 per cent, government at 10 per cent, and non-profit organisations at 3 per cent. Calling on industry to demonstrate India's ability to lead in science, technology, and human welfare, Modi also urged the nation to achieve self-reliance in medicines and innovation, highlighting the country's role as the pharmacy of the world. India currently has around 3,000 pharmaceutical businesses with over 10,500 manufacturing facilities, offering about 60,000 generic brands in 60 therapeutic categories. Many Indian pharmaceutical companies are now pursuing opportunities in generic production for off-patent molecules while building biosimilars pipelines after the Covid-19 pandemic. Pharma firms have stepped up generic launches after several blockbuster molecules used in diabetes medications, such as empagliflozin and dapagliflozin, went off patent in the past two years. Prices of these drugs have fallen by as much as 85 per cent in the Indian market. Similarly, companies such as Sun Pharma, Torrent, Lupin, Glenmark, and Dr Reddy's are working on generic versions of weight-loss drugs based on the blockbuster molecule semaglutide, which is expected to go off patent by March 2026. According to the DoP study paper, more than 300 drug patents across different categories and geographies are set to expire every year during the 'patent cliff' period from 2022 to 2032. 'The patent cliff will provide an opportunity for Indian generic companies to enter the US and other regulated markets and produce more affordable versions of those medications,' the paper added.
